Wasatch Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,416,717
| Closed | -$595K | – | 238 |
|
|
2025
Q4 | $595K | Sell |
1,416,717
-9,736
| -0.7% | -$5.16K | ﹤0.01% | 219 |
|
|
2025
Q3 | $961K | Sell |
1,426,453
-6,657,966
| -82% | -$3.59M | 0.01% | 221 |
|
|
2025
Q2 | $4.38M | Buy |
8,084,419
+1,215,653
| +18% | +$722K | 0.02% | 195 |
|
|
2025
Q1 | $4.5M | Sell |
6,868,766
-2,362,739
| -26% | -$2.5M | 0.03% | 190 |
|
|
2024
Q4 | $9.42M | Sell |
9,231,505
-10,210,863
| -53% | -$18.7M | 0.05% | 163 |
|
|
2024
Q3 | $16.8M | Sell |
19,442,368
-648,202
| -3% | -$475K | 0.08% | 134 |
|
|
2024
Q2 | $7.2M | Sell |
20,090,570
-41,754
| -0.2% | -$22.6K | 0.04% | 176 |
|
|
2024
Q1 | $13.5M | Buy |
20,132,324
+7,734,400
| +62% | +$5.61M | 0.07% | 148 |
|
|
2023
Q4 | $6.74M | Sell |
12,397,924
-5,588,857
| -31% | -$2.58M | 0.04% | 180 |
|
|
2023
Q3 | $10.8M | Buy |
17,986,781
+934,341
| +5% | +$1M | 0.07% | 142 |
|
|
2023
Q2 | $22.2M | Buy |
17,052,440
+3,410,023
| +25% | +$4.66M | 0.13% | 120 |
|
|
2023
Q1 | $24M | Buy |
13,642,417
+991,663
| +8% | +$2.83M | 0.15% | 120 |
|
|
2022
Q4 | $39.7M | Sell |
12,650,754
-471,362
| -4% | -$1.83M | 0.27% | 87 |
|
|
2022
Q3 | $64.3M | Buy |
13,122,116
+729,797
| +6% | +$3.75M | 0.45% | 67 |
|
|
2022
Q2 | $51.3M | Buy |
12,392,319
+1,815,322
| +17% | +$7.85M | 0.32% | 86 |
|
|
2022
Q1 | $61.5M | Sell |
10,576,997
-383,985
| -4% | -$2.28M | 0.3% | 86 |
|
|
2021
Q4 | $82.2M | Buy |
10,960,982
+304,940
| +3% | +$2.65M | 0.34% | 85 |
|
|
2021
Q3 | $96M | Buy |
10,656,042
+351,747
| +3% | +$3.48M | 0.39% | 82 |
|
|
2021
Q2 | $123M | Sell |
10,304,295
-24,128
| -0.2% | -$273K | 0.5% | 69 |
|
|
2021
Q1 | $129M | Buy |
10,328,423
+256,042
| +3% | +$3.45M | 0.58% | 66 |
|
|
2020
Q4 | $157M | Buy |
10,072,381
+2,963,446
| +42% | +$34.7M | 0.77% | 44 |
|
|
2020
Q3 | $67.2M | Buy |
7,108,935
+355,792
| +5% | +$3.85M | 0.43% | 75 |
|
|
2020
Q2 | $60.5M | Buy |
6,753,143
+814,709
| +14% | +$7.56M | 0.44% | 75 |
|
|
2020
Q1 | $37.8M | Sell |
5,938,434
-1,548,583
| -21% | -$11.5M | 0.39% | 71 |
|
|
2019
Q4 | $62.7M | Buy |
7,487,017
+588,494
| +9% | +$5.41M | 0.51% | 63 |
|
|
2019
Q3 | $62.4M | Buy |
6,898,523
+299,615
| +5% | +$3.36M | 0.59% | 61 |
|
|
2019
Q2 | $71.1M | Buy |
6,598,908
+161,000
| +3% | +$1.71M | 0.69% | 55 |
|
|
2019
Q1 | $61.4M | Buy |
6,437,908
+1,359,170
| +27% | +$13.9M | 0.67% | 59 |
|
|
2018
Q4 | $58.3M | Buy |
5,078,738
+534,142
| +12% | +$6.64M | 0.78% | 51 |
|
|
2018
Q3 | $77M | Buy |
4,544,596
+486,429
| +12% | +$7.39M | 0.88% | 41 |
|
|
2018
Q2 | $57.6M | Buy |
4,058,167
+365,186
| +10% | +$6.07M | 0.69% | 54 |
|
|
2018
Q1 | $70.2M | Sell |
3,692,981
-1,005,530
| -21% | -$21.5M | 0.91% | 42 |
|
|
2017
Q4 | $77.1M | Sell |
4,698,511
-492,278
| -9% | -$7.32M | 1.02% | 36 |
|
|
2017
Q3 | $77.9M | Sell |
5,190,789
-1,739,746
| -25% | -$19.2M | 1.06% | 35 |
|
|
2017
Q2 | $61M | Sell |
6,930,535
-129,600
| -2% | -$831K | 0.85% | 46 |
|
|
2017
Q1 | $36.7M | Sell |
7,060,135
-196,125
| -3% | -$787K | 0.54% | 56 |
|
|
2016
Q4 | $22.1M | Buy |
7,256,260
+274,579
| +4% | +$1,000K | 0.33% | 73 |
|
|
2016
Q3 | $32.3M | Buy |
6,981,681
+26,920
| +0.4% | +$137K | 0.48% | 61 |
|
|
2016
Q2 | $40.3M | Buy |
6,954,761
+1,008
| +0% | +$6.42K | 0.62% | 53 |
|
|
2016
Q1 | $39.9M | Buy |
6,953,753
+173,363
| +3% | +$1.04M | 0.61% | 50 |
|
|
2015
Q4 | $61.9M | Sell |
6,780,390
-42,840
| -0.6% | -$330K | 0.85% | 35 |
|
|
2015
Q3 | $38.5M | Buy |
6,823,230
+3,731,844
| +121% | +$30.8M | 0.51% | 67 |
|
|
2015
Q2 | $34.3M | Buy |
3,091,386
+30,799
| +1% | +$397K | 0.37% | 95 |
|
|
2015
Q1 | $48M | Buy |
3,060,587
+88,528
| +3% | +$1.37M | 0.5% | 70 |
|
|
2014
Q4 | $45.2M | Buy |
2,972,059
+1,247
| +0% | +$15.1K | 0.47% | 77 |
|
|
2014
Q3 | $32M | Buy |
2,970,812
+12,866
| +0.4% | +$168K | 0.34% | 103 |
|
|
2014
Q2 | $45.2M | Sell |
2,957,946
-167,214
| -5% | -$2.41M | 0.44% | 77 |
|
|
2014
Q1 | $56.5M | Sell |
3,125,160
-89,072
| -3% | -$1.72M | 0.55% | 54 |
|
|
2013
Q4 | $44.6M | Buy |
3,214,232
+177,174
| +6% | +$2.04M | 0.44% | 80 |
|
|
2013
Q3 | $31.8M | Sell |
3,037,058
-71,424
| -2% | -$709K | 0.33% | 105 |
|
|
2013
Q2 | $24.3M | Buy |
+3,108,482
| New | +$27.1M | 0.27% | 121 |
|
Other funds holding SGMO
AC
VCM
VFT
Wasatch Advisors's SGMO Position: Q1 2026 in Review
Wasatch Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 1,416,717 shares — an estimated $595K sold.
Wasatch Advisors first reported a position in SGMO in Q2 2013 and held it in 51 quarters. The position peaked at $157M in Q4 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.
- Wasatch Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
- Wasatch Advisors sold 1,416,717 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $595K.
- Wasatch Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 51 quarters.
- Wasatch Advisors's SANGAMO THERAPEUTICS INC position peaked at $157M in Q4 2020.
- 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.
Based on Wasatch Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.